Moreover, Stenman and co-workers reported that a MYB-NFIB fusion is a hallmark of adenoid cystic carcinomas (ACC) of the breast, head and neck, and that deregulation of the expression of MYB is a key oncogenic event in the pathogenesis of ACC [18]. This evidence concerns the gene MYB and adenoid cystic carcinoma.